Thyrotoxicosis Diagnosis & Titration Pathway

Clinical Pearls: Thyrotoxicosis

The diagnosis of thyrotoxicosis rests on biochemical confirmation followed by precise aetiological mapping. Incorrectly diagnosing destructive thyroiditis as Graves' disease leads to inappropriate anti-thyroid drug (ATD) exposure.

1. Total vs. Free Hormones

Total T4 and Total T3 assays measure both bound and unbound hormone. Conditions that increase Thyroid Binding Globulin (TBG), such as pregnancy, oral contraceptive use, and acute hepatitis, will falsely elevate Total T4/T3 levels without causing clinical thyrotoxicosis. Always base therapeutic decisions on Free hormone assays when there is discordance.

2. Differentiating the Big Three

3. Beta-Blocker Selection

Propranolol is the preferred non-selective agent because at high doses (typically > 160 mg/day), it blocks the peripheral 5'-deiodinase enzyme, preventing conversion of T4 to the more active T3. However, in patients with asthma or reactive airway disease, cardioselective agents (e.g., Atenolol or Metoprolol) are mandatory to prevent severe bronchospasm.

4. Anti-Thyroid Drugs (ATDs)

Methimazole / Carbimazole is first-line due to once-daily dosing and a lower risk of fulminant hepatic necrosis. Propylthiouracil (PTU) is strictly reserved for the first trimester of pregnancy (to avoid methimazole-associated embryopathy like aplasia cutis) or in the acute management of Thyroid Storm (due to its additional peripheral T4-to-T3 blocking effect).